ClinicalTrials.gg
RecruitingNCT07726030Updated Sep 30, 2026

Effects of Rotator Cuff Drills Versus Progressive Resistance Exercises on Chronic Rotator Cuff Tendinopathy

An interventional study of Rotator cuff Drills and Progressive resistance exercises in Rotator Cuff Tendinosis, sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to male participants aged 17 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-09-30.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Oct 2025, registered Jul 2026).
  • Started Oct 2025; still recruiting 1 year 1 month later.
Updated Sep 30, 2026Primary completion movedStudy completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
17 Years to 35 Years
Sex
Male
01

Study summary

A single-blinded randomized clinical trial was conducted with 30 male overhead athletes (17-35 years) recruited from cricket clubs and sports complexes in Faisalabad. Participants were randomized into Group A (rotator cuff drills: plyometric medicine ball throws, wall dribbles) or Group B (PREs: resistance band exercises with progressive loading). Both groups underwent 12-week interventions (3 sessions/week) following the FIIT principle (Frequency, Intensity, Time, Type), preceded by a standardized 20-minute warm-up. Outcomes were assessed using the Numeric Pain Rating Scale (NPRS), Shoulder Pain and Disability Index (SPADI), Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST), and Upper Limb Rotation Test (ULRT) at baseline, 6 weeks, and 12 weeks. Data were analyzed using SPSS v24, with statistical significance set at *p* ≤ 0.05. Descriptive statistics (mean, SD) summarized continuous variables, while frequencies/percentages described categorical data. Normality was confirmed via Kolmogorov-Smirnov test. Between-group differences were analyzed using independent *t*-tests, and within-group changes via paired *t*-tests. The study's rigorous blinding and standardized protocols minimized bias, ensuring robust comparisons between interventions.

Read the detailed description

Rotator cuff tendinopathy is a prevalent condition among overhead athletes, significantly impairing performance and function. While both rotator cuff drills and progressive resistance exercises (PREs) are commonly used in rehabilitation, there remains a lack of comparative evidence on their effectiveness, particularly in sport-specific contexts.

Current literature highlights gaps in optimal exercise progression, long-term outcomes, and objective performance metrics for overhead athletes. This study aims to compare these two interventions to determine which approach better improves pain, stability, and functional performance in athletes with chronic rotator cuff tendinopathy, addressing a critical need for evidence-based rehabilitation protocols in sports medicine. A single-blinded randomized clinical trial was conducted with 30 male overhead athletes (17-35 years) recruited from cricket clubs and sports complexes in Faisalabad. Participants were randomized into Group A (rotator cuff drills: plyometric medicine ball throws, wall dribbles) or Group B (PREs: resistance band exercises with progressive loading). Both groups underwent 12-week interventions (3 sessions/week) following the FIIT principle (Frequency, Intensity, Time, Type), preceded by a standardized 20-minute warm-up. Outcomes were assessed using the Numeric Pain Rating Scale (NPRS), Shoulder Pain and Disability Index (SPADI), Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST), and Upper Limb Rotation Test (ULRT) at baseline, 6 weeks, and 12 weeks. Data were analyzed using SPSS v24, with statistical significance set at *p* ≤ 0.05. Descriptive statistics (mean, SD) summarized continuous variables, while frequencies/percentages described categorical data. Normality was confirmed via Kolmogorov-Smirnov test. Between-group differences were analyzed using independent *t*-tests, and within-group changes via paired *t*-tests. The study's rigorous blinding and standardized protocols minimized bias, ensuring robust comparisons between interventions.

02

Conditions studied

  • Rotator Cuff Tendinosis

Keywords

  • Overhead Athletes
  • Rotator cuff tendinopathy
  • Shoulder pain
  • Sports rehabilitation
03

In context

Rotator Cuff Injuries

631 studies on the registry are indexed under Rotator Cuff Injuries; 156 are open to participants now.

This study's planned enrollment of 30 is below the median of 60 across 456 interventional studies indexed under Rotator Cuff Injuries.

Browse Rotator Cuff Injuries studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,194 studies on the registry; 650 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
17 Years to 35 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Professional male overhead athletes aged 17-35 years
  • Male overhead athletes playing competitive sports like volleyball, tennis, baseball, cricket, swimming, badminton, and basketball for at least 6 hours a week. Painful arc of movement during flexion or abduction.
  • Positive Neer's or Kennedy-Hawkins test

Exclusion criteria

Exclusion Criteria:

  • Had a previous shoulder surgery.
  • Trauma history. injection within the previous 6 weeks
  • Other injuries rather than Rotator cuff tendinopathy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Rotator Cuff Drills

    Rotator cuff Drills

    Other: Rotator cuff Drills

  • Experimental
    Progressive Resistance exercises

    Progressive resistance exercises

    Other: Progressive resistance exercises

Interventions

  • OtherRotator cuff Drills

    (rotator cuff drills: plyometric medicine ball throws, wall dribbles)

  • OtherProgressive resistance exercises

    PREs: resistance band exercises with progressive loading). Both groups underwent 12-week interventions (3 sessions/week) following the FIIT principle (Frequency, Intensity, Time, Type), preceded by a standardized 20-minute warm-up.

06

What researchers measure

Primary outcomes

  1. Pain through NPRS

    The Numeric Pain Rating Scale (NPRS) is an 11-point pain intensity scale where patients rate their pain from 0 (no pain) to 10 (worst imaginable pain),

    Time frame: Pre and 6 week post interventional

  2. CKCUEST Scale

    The Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST) is a rapid, low-cost functional assessment tool used by physical therapists and sports medicine professionals to quantify shoulder stability, upper-limb power, and trunk control.

    Time frame: Pre and 6 week post interventional

  3. ULRT Test

    The Upper Limb Rotation Test (ULRT) is a physical performance test used in sports medicine and physiotherapy to assess shoulder control, closed-chain stability, and trunk rotation.

    Time frame: Pre and 6 week post interventional

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2025 (actual). Primary completion is estimated for Oct 2026, 12 months after the start.

Of 228 non-industry interventional studies with no phase under Rotator Cuff Injuries, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's planned 12 months is below that.

Counting every sponsor, half of 252 studies reached it within 23 months; a quarter within 11 and three quarters within 44.

Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 30, 2026: primary completion Jul 2026 → Oct 2026 and completion Jul 2026 → Oct 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 21, 2026
First posted
Jul 24, 2026
StartActual
Oct 15, 2025
Primary completionEst.
Oct 2026was Jul 2026
CompletionEst.
Oct 2026was Jul 2026
Last update
Sep 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jul 15, 2026→Oct 2026
Sep 30, 2026
Study completion
Jul 30, 2026→Oct 2026
Sep 30, 2026
Primary outcomes
2 added, 2 removed, 1 description edited
What changed in the outcomes
  • AddedCKCUEST ScaleTime frame: Pre and 6 week post interventional
  • AddedULRT TestTime frame: Pre and 6 week post interventional
  • Removedstability through CKCUESTTime frame: Pre and 6 week post interventional
  • Removedfunctional performance through ULRTTime frame: Pre and 6 week post interventional
  • DescriptionPain through NPRS: how it is measured was reworded
Sep 30, 2026
Show all 1 update
  1. Sep 30, 2026
    Primary completion Jul 15, 2026→Oct 2026
    Study completion Jul 30, 2026→Oct 2026
    Primary outcomes 2 added, 2 removed, 1 description edited
    What changed in the outcomes
    • AddedCKCUEST ScaleTime frame: Pre and 6 week post interventional
    • AddedULRT TestTime frame: Pre and 6 week post interventional
    • Removedstability through CKCUESTTime frame: Pre and 6 week post interventional
    • Removedfunctional performance through ULRTTime frame: Pre and 6 week post interventional
    • DescriptionPain through NPRS: how it is measured was reworded
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07726030
Responsible party
Sponsor
First posted
Jul 24, 2026
Start date
Oct 15, 2025
Primary completion
Oct 2026 (estimated)
Completion
Oct 2026 (estimated)
Last update
Sep 30, 2026

Study contacts

Amna Shahid, t-dpt
Contact
amna.shahid@riphah.edu.pk
0334-4512823
Husnain Mahmood, DPT
principal investigator · Study Principal Investigator

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion